NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SensArs Neuroprosthetics

SensArs Neuroprosthetics

Private
LausanneHealthcare & Life Scienceshttps://www.sensars.com/

Last Round

Grant

May 1, 2024

Total Funding Raised

$4.63M

Company Overview

SensArs Neuroprosthetics is a medical technology company that develops implantable neuroprosthetics to restore sensation for amputees and patients with nerve damage.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Biotechnology, Medical AI, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

implantable neuroprostheticsneurostimulation systemsensory restorationbionic limbsphantom limb painchronic neuropathic painperipheral nerve stimulationneurotechclosed-loop neurostimulationamputee prostheticsmedical AIwearable sensorsgait analysisdiabetic neuropathyFDA Breakthrough Device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SensArs Neuroprosthetics Comparables

Compare SensArs Neuroprosthetics with similar companies based on industry and business-model similarity.

SensArs Neuroprosthetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MYNERVA AG
76%
Atom Limbs
70%
Integrum
69%

SensArs Neuroprosthetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2024
Pre SeedMay 1, 2024
GrantMay 1, 2024
GrantOct 8, 2019
GrantJul 3, 2017
Accelerator
Feb 15, 2017

Key People

Founding team and executive leadership

Francesco Maria Petrini

Founder, CEO

Founding Team

Todd Hauser

Founding CFO, Angel Investor

Founding Team

SensArs Neuroprosthetics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors grew 730% MoM, from 197 to 1.6K.

  • Oct 16, 2025

    Grew 167% QoQ from 3 to 8 employees.

SensArs Neuroprosthetics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SensArs Neuroprosthetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SensArs Neuroprosthetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range10
Year Founded2014
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.